Physician profile
Mark Christopher Molnar
NPI 1386687309
$980.30
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $94.70 · 2021: $261 · 2022: $79.95 · 2023: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $94.00 · Food and Beverage: $16.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $94.00 |
| Food and Beverage | $16.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $299.69 | 2019-2021 | |
| Avion Pharmaceuticals | $97.66 | 2019-2022 | |
| Astellas Pharma US INC | $94.00 | 2023 | |
| Therapeuticsmd, INC. | $90.12 | 2019-2022 | |
| Minerva Surgical, INC | $72.54 | 2019 | |
| Exeltis, USA INC. | $63.35 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.58 | 2019-2023 | |
| Pfizer INC. | $40.91 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $33.35 | 2019 | |
| Lupin INC. | $30.25 | 2019-2020 | |
| Vapotherm INC | $22.33 | 2019 | |
| Smith+Nephew, INC. | $17.92 | 2019 | |
| Mayne Pharma Commercial LLC | $15.62 | 2021 | |
| Allergan, INC. | $15.35 | 2019 | |
| Intuitive Surgical, INC. | $14.08 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $12.86 | 2020 | |
| Merck Sharp & Dohme LLC | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Molnar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.